Seagen Says Tukysa Plus Kadcyla Showed 'Significant Improvement" in Breast Cancer Patients' Progression-Free Survival
Seagen Says Tukysa Plus Kadcyla Showed 'Significant Improvement" in Breast Cancer Patients' Progression-Free Survival
西根說，Tukysa Plus Kadcyla在乳腺癌患者的無進展存活率方面顯示 “顯著改善”
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊